Plerixafor Accord Evropska unija - norveščina - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Dexametason Abcur 1 mg Norveška - norveščina - Statens legemiddelverk

dexametason abcur 1 mg

abcur ab - deksametason - tablett - 1 mg

Dexametason Abcur 4 mg Norveška - norveščina - Statens legemiddelverk

dexametason abcur 4 mg

abcur ab - deksametason - tablett - 4 mg

Oxaliplatin Fresenius Kabi 5 mg/ ml Norveška - norveščina - Statens legemiddelverk

oxaliplatin fresenius kabi 5 mg/ ml

fresenius kabi norge as - oksaliplatin - konsentrat til infusjonsvæske, oppløsning - 5 mg/ ml

Dexamethasone Krka 4 mg Norveška - norveščina - Statens legemiddelverk

dexamethasone krka 4 mg

krka, d.d. novo mesto - deksametason - tablett - 4 mg

Dexavit 4 mg/ ml Norveška - norveščina - Statens legemiddelverk

dexavit 4 mg/ ml

vital pharma nordic aps - deksametasonnatriumfosfat - injeksjons-/infusjonsvæske, oppløsning - 4 mg/ ml

Dexacur 4 mg/ ml Norveška - norveščina - Statens legemiddelverk

dexacur 4 mg/ ml

abboxia ab - deksametasonnatriumfosfat - injeksjons-/infusjonsvæske, oppløsning - 4 mg/ ml

Dexadreson vet 2 mg/ ml Norveška - norveščina - Statens legemiddelverk

dexadreson vet 2 mg/ ml

intervet international bv - 5831 an - deksametasonnatriumfosfat - injeksjonsvæske, oppløsning - 2 mg/ ml

Dexaject 2 mg/ ml Norveška - norveščina - Statens legemiddelverk

dexaject 2 mg/ ml

dopharma research b.v. - deksametason - injeksjonsvæske, oppløsning - 2 mg/ ml

Raplixa Evropska unija - norveščina - EMA (European Medicines Agency)

raplixa

mallinckrodt pharmaceuticals ireland limited - human fibrinogen, human trombin - hemostase, kirurgisk - antihemoragika - støttende behandling der standard kirurgiske teknikker er utilstrekkelige for forbedring av hemostase. raplixa må brukes i kombinasjon med en godkjent gelatin svamp. raplixa er indisert hos voksne over 18 år.